Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13

Rheumatology International

Volumn 33, Issue 5, 2013, Pages 1313-1319

  Xu, Mai ^a   Zhang, Lu ^a   Zhao, Lei ^b   Gao, Shuguang ^a   Han, Rui ^c   Su, Dazhi ^d   Lei, Guanghua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c Qingdao Haici Hospital   (China)

^d ZHUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Matrix metalloproteinase 13; Osteoarthritis; Osteopontin; Phosphorylation

Indexed keywords

COLLAGENASE 3; OSTEOPONTIN;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOPRECIPITATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CARTILAGE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHONDROCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPRECIPITATION; KNEE JOINT; MATRIX METALLOPROTEINASE 13; OSTEOARTHRITIS, KNEE; OSTEOPONTIN; PHOSPHORYLATION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84878018207     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2548-4     Document Type: Article

References (36)

1. Buckwalter JA, Martin JA (2006) Osteoarthritis. Adv Drug Deliv Rev 58(2):150-167. doi: 10.1016/j.addr.2006.01.006
2. Aigner T, Fundel K, Saas J, Gebhard PM, Haag J, Weiss T, Zien A, Obermayr F, Zimmer R, Bartnik E (2006) Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 54(11):3533-3544. doi: 10.1002/art.22174
3. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G (1996) Biochemical characterization of human collagenase-3. J Biol Chem 271(3):1544-1550
4. Otero M, Plumb DA, Tsuchimochi K, Dragomir CL, Hashimoto K, Peng H, Olivotto E, Bevilacqua M, Tan L, Yang Z, Zhan Y, Oettgen P, Li Y, Marcu KB, Goldring MB (2012) E74-like factor 3 (ELF3) impacts on matrix metalloproteinase 13 (MMP13) transcriptional control in articular chondrocytes under proinflammatory stress. J Biol Chem 287(5):3559-3572. doi: 10.1074/jbc.M111. 265744
5. Yin J, Yang Z, Cao YP, Ge ZG (2011) Characterization of human primary chondrocytes of osteoarthritic cartilage at varying severity. Chin Med J 124(24):4245-4253
6. Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44(3):585-594. doi: 10.1002/1529-0131(200103)44:3<585:AID-ANR107>3.0.CO;2- C
7. Buckland J (2012) Osteoarthritis: complement-mediated inflammation in OA progression. Nat Rev Rheumatol 8(1):2. doi: 10.1038/nrrheum.2011.182
8. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7(1):33-42. doi: 10.1038/nrrheum.2010.196
9. Hasegawa M, Segawa T, Maeda M, Yoshida T, Sudo A (2011) Thrombin-cleaved osteopontin levels in synovial fluid correlate with disease severity of knee osteoarthritis. J Rheumatol 38(1):129-134. doi: 10.3899/jrheum.100637
10. Gao SG, Li KH, Zeng KB, Tu M, Xu M, Lei GH (2010) Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthr Cartil/OARS Osteoarthr Res Soc 18(1):82-87. doi: 10.1016/j.joca.2009.07.009
11. Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M, Yuktanandana P (2009) Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 42(9):808-812. doi: 10.1016/j.clinbiochem.2009.02.002
12. Martin I, Jakob M, Schafer D, Dick W, Spagnoli G, Heberer M (2001) Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthr Cartil/OARS, Osteoarthr Res Soc 9(2):112-118. doi: 10.1053/joca.2000.0366
13. Pullig O, Weseloh G, Gauer S, Swoboda B (2000) Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol 19(3):245-255
14. Qin C, Baba O, Butler WT (2004) Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Critical Rev Oral Biol Med 15(3):126-136
15. Sodek J, Ganss B, McKee MD (2000) Osteopontin. Crit Rev Oral Biol Med 11(3):279-303
16. Christensen B, Klaning E, Nielsen MS, Andersen MH, Sorensen ES (2012) C-terminal modification of osteopontin inhibits interaction with the alphaVbeta3-integrin. J Biol Chem 287(6):3788-3797. doi: 10.1074/jbc.M111.277996
17. Christensen B, Kazanecki CC, Petersen TE, Rittling SR, Denhardt DT, Sorensen ES (2007) Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J Biol Chem 282(27):19463-19472. doi: 10.1074/jbc.M703055200
18. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF (2011) Pre- and post-translational regulation of osteopontin in cancer. J Cell Commun Signal 5(2):111-122. doi: 10.1007/s12079-011-0130-6
19. Rasheed Z, Akhtar N, Haqqi TM (2010) Pomegranate extract inhibits the interleukin-1beta-induced activation of MKK-3, p38alpha-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes. Arthritis Res Ther 12(5):R195. doi: 10.1186/ar3166
20. Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Jt Surg Am Vol 53(3):523-537
21. Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mansson H (2007) The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 16(6):1087-1097. doi: 10.1158/1055-9965.EPI-06-1008
22. O'Regan A (2003) The role of osteopontin in lung disease. Cytokine Growth Factor Rev 14(6):479-488
23. McKee MD, Pedraza CE, Kaartinen MT (2011) Osteopontin and wound healing in bone. Cells Tissues Organs 194(2-4):313-319. doi: 10.1159/000324244
24. Buback F, Renkl AC, Schulz G, Weiss JM (2009) Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol 18(9):750-759. doi: 10.1111/j.1600-0625.2009.00926.x
25. Haylock DN, Nilsson SK (2006) Osteopontin: a bridge between bone and blood. Br J Haematol 134(5):467-474. doi: 10.1111/j.1365-2141.2006.06218.x
26. Gravallese EM (2003) Osteopontin: a bridge between bone and the immune system. J Clin Investig 112(2):147-149. doi: 10.1172/JCI19190
27. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S (2002) Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol 72(4):752-761
28. Al-Shami R, Sorensen ES, Ek-Rylander B, Andersson G, Carson DD, Farach-Carson MC (2005) Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway. J Cell Biochem 94(6):1218-1233. doi: 10.1002/jcb.20379
29. Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G (1994) Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269(21):14853-14856
30. Ek-Rylander B, Andersson G (2010) Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp Cell Res 316(3):443-451. doi: 10.1016/j.yexcr.2009.10.019
31. Zhang FJ, Gao SG, Cheng L, Tian J, Xu WS, Luo W, Song Y, Yang Y, Lei GH (2012) The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee. Rheumatol Int. doi: 10.1007/s00296-011-2339-3
32. Matsui Y, Iwasaki N, Kon S, Takahashi D, Morimoto J, Denhardt DT, Rittling S, Minami A, Uede T (2009) Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum 60(8):2362-2371. doi: 10.1002/art.24705
33. Morimoto J, Kon S, Matsui Y, Uede T (2010) Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets 11(4):494-505
34. Mori N, Majima T, Iwasaki N, Kon S, Miyakawa K, Kimura C, Tanaka K, Denhardt DT, Rittling S, Minami A, Uede T (2007) The role of osteopontin in tendon tissue remodeling after denervation-induced mechanical stress deprivation. Matrix Biol 26(1):42-53. doi: 10.1016/j.matbio.2006.09.002
35. Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sorensen ES (2005) Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J 390(Pt 1):285-292. doi: 10.1042/BJ20050341
36. Li X, Li J, Cheng K, Lin Q, Wang D, Zhang H, An H, Gao M, Chen A (2011) Effect of low-intensity pulsed ultrasound on MMP-13 and MAPKs signaling pathway in rabbit knee osteoarthritis. Cell Biochem Biophys 61(2):427-434. doi: 10.1007/s12013-011-9206-4